Zevalin-BEAM/BEAC With Autologous Stem Cell Support as Consolidation in First Line Treatment of Mantle Cell Lymphoma
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine if outcome for patients with mantle cell lymphoma is
improved by adding radioimmunotherapy to high-dose regimen before auto-transplant in patients
who are not in CR after induction therapy.